dc.contributor.author | Agouni, Abdelali | |
dc.contributor.author | Tual-Chalot, Simon | |
dc.contributor.author | Chalopin, Matthieu | |
dc.contributor.author | Duluc, Lucie | |
dc.contributor.author | Mody, Nimesh | |
dc.contributor.author | Martinez, M. Carmen | |
dc.contributor.author | Andriantsitohaina, Ramaroson | |
dc.contributor.author | Delibegovic, Mirela | |
dc.date.accessioned | 2014-12-04T13:49:01Z | |
dc.date.available | 2014-12-04T13:49:01Z | |
dc.date.issued | 2014-12-15 | |
dc.identifier | 43244449 | |
dc.identifier | 88c33cb3-2081-4a72-981f-468000d80270 | |
dc.identifier | 84912144588 | |
dc.identifier.citation | Agouni , A , Tual-Chalot , S , Chalopin , M , Duluc , L , Mody , N , Martinez , M C , Andriantsitohaina , R & Delibegovic , M 2014 , ' Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction ' , Biochemical Pharmacology , vol. 92 , no. 4 , pp. 607-617 . https://doi.org/10.1016/j.bcp.2014.10.008 | en |
dc.identifier.issn | 0006-2952 | |
dc.identifier.other | ORCID: /0000-0002-2215-7952/work/36967422 | |
dc.identifier.uri | http://hdl.handle.net/2164/4076 | |
dc.description | Acknowledgments This work was supported by a Diabetes UK project grant to Dr M. Delibegović (BDARD08/0003597), Tenovus Scotland grant to Dr. M. Delibegovic and Dr. A. Agouni and travel grants from the Physiological Society and Company of Biologists to Dr. A. Agouni. Dr Delibegovic is also funded by an RCUK Fellowship, British Heart Foundation, EFSD/Lilly diabetes programme grant and the Royal Society. Dr Agouni is funded by the Royal Society and the Physiological Society. This work is supported by the INSERM and CHU of Angers. The authors are thankful to the functional imaging center of Angers (CIFAB) for the use of echocardiography. | en |
dc.format.extent | 11 | |
dc.format.extent | 1190693 | |
dc.language.iso | eng | |
dc.relation.ispartof | Biochemical Pharmacology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | PTP1B | en |
dc.subject | insulin resistance | en |
dc.subject | endothelial dysfunction | en |
dc.subject | tyrosine phosphatase | en |
dc.subject | eNOS | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/j.bcp.2014.10.008 | |
dc.identifier.url | http://authors.elsevier.com/a/1Q61R1Rct-f-r | en |